5536
antibody from Cell Signaling Technology, Inc
Targeting: MTOR
FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 5536 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#5536, RRID:AB_10691552
- Product name
- Phospho-mTOR (Ser2448) (D9C2) XP® Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.
The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.
The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Murai A, Asa SA, Kodama A, Hirata A, Yanai T, Sakai H
BMC veterinary research 2012 Jul 29;8:128
BMC veterinary research 2012 Jul 29;8:128
The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.
Sarfstein R, Bruchim I, Fishman A, Werner H
PloS one 2011;6(9):e24468
PloS one 2011;6(9):e24468
The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K, Pfeilschifter J, Gutwein P
Carcinogenesis 2011 Nov;32(11):1713-23
Carcinogenesis 2011 Nov;32(11):1713-23
No comments: Submit comment
No validations: Submit validation data